Drawing for NATURASON

USPTO serial 76122111

NATURASON

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
MICHOS, JOHN E
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with NATURASON?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Viviana Amzel

VIVIANA AMZEL EPIGENESIS PHARMACEUTICALS, INC7 CLARKE DRCRANBURY, NJ 08512UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations, namely, steroid hormone compound(s), including dehydroepiandrosterone derivatives and salts, for medical use, in the treatment of human and non-human animal respiratory, central nervous system, immune, endocrine, neoplastic and cardiovascular conditions, including bronchoconstriction, anxiety, Pre Menstrual Syndrome, Menopause symptoms, anxiety, lack of sleep, aggressive or ostensibly socially inappropriate behavior, difficult breathing, impeded and obstructed lung airways, allergy(ies) and/or inflammation, pharmaceutical preparations for testing, preventing and therapeutically treating immune, central nervous system, endocrine, neoplastic, cardiovascular, respiratory, airway and pulmonary diseases and conditions, such as asthma, pulmonary vasoconstriction, inflammation, allergies, asthma, impeded respiration, Acute Respiratory Distress Syndrome (ARDS), renal damage and failure, ischemia, associated with the administration of certain drugs, including adenosine and other drugs for, for example, treating SupraVentricular Tachycardia (SVT), adenosine stress tests, infantile Respiratory Distress Syndrome (infantile RDS), pain, cystic fibrosis, allergic rhinitis, allergic bronchitis, pulmonary hypertension, pulmonary vasoconstriction, emphysema, chronic obstructive pulmonary disease (COPD), as well as cancers including leukemias, lymphomas, carcinomas, and the like, eg colon cancer, breast cancer, lung cancer, pancreatic cancer, hepatocellular carcinoma, kidney cancer, melanoma, etc, as well as all metastatic cancers, eg cancers which metastasized to the lung(s), breast and prostate includedACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (ABN6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Sep 24, 2003ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 7, 2003NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 15, 2002PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 25, 2002NPUBNOTICE OF PUBLICATION—
Jul 15, 2002CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 5, 2002DOCKASSIGNED TO EXAMINER—
Jun 19, 20021.BASec. 1(B) CLAIM ADDED—
Jun 19, 20021.ADSEC. 1(A) CLAIM DELETED—
Jun 12, 2002CNEAEXAMINERS AMENDMENT MAILED—
Mar 5, 2002CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 7, 2001CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 10, 2001CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 7, 2001CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 24, 2001DOCKASSIGNED TO EXAMINER—
Jan 23, 2001DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance